CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
TAK-536drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03434977
NCT03434977Phase 1Completed
CompareCT.gov

A Randomized, Open-Label, Cross-over Phase 1 Study to Evaluate the Food Effect of Single Oral Dose of TAK-536 Pediatric Formulation in Healthy Adult Male Subjects

Takeda·interventional·Posted Feb 15, 2018·Updated Jun 10, 2019

In Brief

A Phase 1 clinical trial evaluating TAK-536 for Healthy Volunteers. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the PK of TAK-536 and effect of food on the PK following single oral administration of TAK-536 pediatric formulation in Japanese healthy adult male participants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesJapan
Collaborators--

Timeline

Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedFeb 15, 2018
Enrollment StartFeb 14, 2018
Primary CompletionMar 11, 2018
TodayJul 2, 2026
Enrollment to primary: 27 daysPosted 8.4 years ago

Interventions

TAK-536drug

TAK-536 granule formulation